[18F]Fluoromisonidazole PET in rectal cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2191-219X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: [18F]Fluoromisonidazole PET in rectal cancer ; volume:7 ; number:1 ; day:20 ; month:9 ; year:2017 ; pages:1-17 ; date:12.2017
EJNMMI Research ; 7, Heft 1 (20.9.2017), 1-17, 12.2017

Keyword: Krebs
Onkologie

Creator: Puri, Tanuj

Contributor: Greenhalgh, Tessa A.
Wilson, James M.
Franklin, Jamie
Wang, Lia Mun
Strauss, Victoria
Cunningham, Chris
Partridge, Mike
Maughan, Tim
SpringerLink (Online service)

DOI: 10.1186/s13550-017-0324-x

URN: urn:nbn:de:1111-2017111986

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Puri, Tanuj
Greenhalgh, Tessa A.
Wilson, James M.
Franklin, Jamie
Wang, Lia Mun
Strauss, Victoria
Cunningham, Chris
Partridge, Mike
Maughan, Tim
SpringerLink (Online service)

Other Objects (12)

[18F]FDG PET/MRI in rectal cancer

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

FDG-PET/CT in predicting aggressiveness of rectal cancer

Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study

Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid 18F-FDG PET/MR: Preliminary Results in Rectal Cancer

Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

[18F]FDG PET/MRI in rectal cancer

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

FDG-PET/CT in predicting aggressiveness of rectal cancer

Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study

Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid 18F-FDG PET/MR: Preliminary Results in Rectal Cancer

Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

[18F]FDG PET/MRI in rectal cancer

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

FDG-PET/CT in predicting aggressiveness of rectal cancer

Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study

Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid 18F-FDG PET/MR: Preliminary Results in Rectal Cancer

Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

[18F]Fluoromisonidazole PET in rectal cancer

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

[18F]FDG PET/MRI in rectal cancer

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

FDG-PET/CT in predicting aggressiveness of rectal cancer

Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study

Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid 18F-FDG PET/MR: Preliminary Results in Rectal Cancer

Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

[18F]FDG PET/MRI in rectal cancer

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

FDG-PET/CT in predicting aggressiveness of rectal cancer

Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study

Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid 18F-FDG PET/MR: Preliminary Results in Rectal Cancer

Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

[18F]FDG PET/MRI in rectal cancer

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

FDG-PET/CT in predicting aggressiveness of rectal cancer

Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study

Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid 18F-FDG PET/MR: Preliminary Results in Rectal Cancer

Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

Related objects

Reset password